HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
CA M43 antigen
a serum marker for colorectal cancer
Also Known As:
CA M43; mucin CA M43
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Carbohydrates: 22023
Glycoconjugates: 1353
Glycoproteins: 24834
Mucoproteins: 203
Mucins: 10505
CA M43 antigen: 1
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Glycoproteins: 24834
Mucoproteins: 203
Mucins: 10505
CA M43 antigen: 1
Biological Factors: 2472
Biomarkers: 240291
Tumor Biomarkers: 15272
Carbohydrate Tumor-Associated Antigens: 355
CA M43 antigen: 1
Antigens: 143924
Epitopes: 19548
Carbohydrate Tumor-Associated Antigens: 355
CA M43 antigen: 1
Neoplasm Antigens: 6217
Carbohydrate Tumor-Associated Antigens: 355
CA M43 antigen: 1
Related Diseases
1.
Colorectal Neoplasms (Colorectal Cancer)
06/01/1993 - "
Evaluation of colorectal cancer-associated mucin CA M43 assay in serum.
"
06/01/1993 - "
In colorectal cancer patients, CA M43 showed a positivity rate equivalent to that of carcinoembryonic antigen (CEA) and superior to that of CA 19.9, with only one CA 19.9-positive serum being negative for CA M43.
"
06/01/1993 - "
The technical performance of a newly developed assay for CA M43, a serum marker for colorectal cancer, was evaluated and its preliminary clinical potential assessed.
"
06/01/1993 - "
The heterologous double-determinant enzyme immunoassay for the detection of the tumor-associated mucin CA M43 utilizes two monoclonal antibodies (CT 43 and CT 66) selected for their binding capacity to two distinct epitopes present on mucins in the sera of patients with colorectal cancer.
"
2.
Neoplasms (Cancer)
06/01/1993 - "
The heterologous double-determinant enzyme immunoassay for the detection of the tumor-associated mucin CA M43 utilizes two monoclonal antibodies (CT 43 and CT 66) selected for their binding capacity to two distinct epitopes present on mucins in the sera of patients with colorectal cancer.
"
Related Drugs and Biologics
1.
Biomarkers (Surrogate Marker)
2.
Mucins
3.
Enzymes
4.
Carcinoembryonic Antigen
5.
Epitopes
6.
Monoclonal Antibodies